Annovis Bio, Inc. - 8-K Filing

Annovis Bio corrected audit fees in its proxy statement for fiscal years 2025 and 2024.

3 articles from 1 source · updated October 21, 2026, 21:44 UTC

Coverage

• PALISADE BIO, INC. - 4 Filing SEC EDGAR · October 21, 2026, 21:44 UTC
• Inmune Bio, Inc. - 8-K Filing SEC EDGAR · October 21, 2026, 13:01 UTC
• Annovis Bio, Inc. - 8-K Filing SEC EDGAR · October 20, 2026, 10:02 UTC